Global Intrauterine Contraceptive Device Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023

Industry : HealthcarePublished Date : January 31st, 2018
Tutorials Get 15% Discount on First Report

The global intra-uterine contraceptive device market is expected to increase from USD 3.80 billion in 2016 to USD 5.27 billion in 2023, at a CAGR of 4.80% from 2017 to 2023. The growth of the intra-uterine contraceptive device market across the globe is attributed to increasing number of birth rate, growing awareness among people, and better technological advancement in the healthcare sector. The years used for the assessment are as follows;

Historical year: 2013, 2014, 2015

Base year: 2016

Forecast period: 2017 – 2023

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total intra-uterine contraceptive device market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global intra-uterine contraceptive device market
  • Finalizing the overall size and shareof the global intra-uterine contraceptive device market

OBJECTIVES:

  • To classify the global intra-uterine contraceptive device market into segments on the basis of type, and end-user and analyze their growth prospects individually
  • To analyze market trends, opportunities, drivers,and restraints associated with the intra-uterine contraceptive device market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the intra-uterine contraceptive device market and provide their competitive landscape

MARKET SCOPE

The research scope for intra-uterine contraceptive device market is as follows:

By Type

  • Hormonal Intra-UterineContraceptive Device
    • Skyla
    • Mirena
    • Kyleena
  • Copper Intra-UterineContraceptive Device
    • U-shaped
    • Plain T-shaped
    • Banded T-shaped

By End-User

  • Gynaecology Clinic
  • Hospitals

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

The global intra-uterine contraceptive device market is expected to grow steadily from USD 3.80 billion in 2016 to USD 5.27 billion in 2023, at a CAGR of 4.80% from 2017 to 2023. Factors driving the growth of intra-uterine contraceptive device market are increasing number of birth rate, growing awareness among people, and better technological advancement in the healthcare sector. Moreover, government initiatives to prevent unwanted abortions and pregnancies are further augmenting the growth of the global intra-uterine contraceptive device market. However, lack of trained people in rural areas, and religious or culture opposition are hindering the growth of the global intra-uterine contraceptive device market.

Intra-uterine contraceptive device (IUDs) is a T-shaped, plastic contraceptive device that is inserted into the uterus by a healthcare professional to prevent unwanted pregnancy by inhibiting the fertilization of the egg. The intra-uterine contraceptive device is also known as long-acting reversible contraception (LARCs) as they are used for long time with the reversible facility.

On the basis of types, the hormonal intra-uterine contraceptive device (Mirena) held the major share of the global intra-uterine contraceptive device market in 2016 and is expected to hold its dominance during the forecast period, mainly due to wide use of the hormonal intra-uterine contraceptive device among people. Hormonal intra-uterine contraceptive device (Mirena) is mainly used as it is easy to access, prolongs time to prevent the pregnancy, and has fewer side effects in comparison to other devices. On the basis of end-user, hospitals held the major share in 2016.

Geographically, Asia-Pacific holds the major market share of the global intra-uterine contraceptive device market and is projected to remain key market over the forecast period.The demand for these devices is attributed to growing population of China and India, coupled with increasing government initiatives to prevent unwanted abortions and pregnancies. Europe is expected to become the second largest intra-uterine contraceptive device market over the forecast period.The growth in the region is attributed to new technological innovations,and awareness to use of intra-uterine contraceptive device among people.

Some of the major players in the intra-uterine contraceptive device market include; TEVA PHARMACEUTICAL INDUSTRIES LIMITED, EGEMEN INTERNATIONAL, Bayer HealthCare Pharmaceuticals Inc, Agile Therapeutics, Allergan pl, Pfizer, Lupin Pharmaceuticals Ltd, Pregna International Ltd., SMB CORPORATION, Trimedic Supply Network Ltd among others.

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Market Definition

1.2. Market Segmentation

1.2.1. Market Breakdown, By Types

1.2.2. Market Breakdown, By End-User

1.2.3. Market Breakdown, By Region

1.3. Research Methodology

1.3.1. Initial Data Search

1.3.2. Secondary Research

1.3.3. Primary Research

1.3.4. Scope and Assumptions

1.4. Sources

1.5. Executive Summary

CHAPTER 2. Market Outlook

2.1. Introduction

2.2. Market Outlook

 2.2.1. Opportunities

2.2.1.1. Low failure rate and fewer side effects

2.2.1.2. Increase in government initiative to control birth rate and avoid abortions

 2.2.2. Trends

2.2.2.1. Healthcare technology advancement and growing awareness among people

2.2.2.2. Long-acting reversible contraceptives

2.2.2.3. Government and commercial organization initiatives promoting IUDs

  2.2.3. Growth Drivers

2.2.3.1. More effective in preventing pregnancy

2.2.3.2. Cost effective and long-term usability

2.2.3.3. Easy carry out operation as per convenience

    2.2.4. Impact Analysis of Drivers on Future Forecast of the Market

   2.2.5. Restraints of the Market

2.2.5.1. Lack of skilled people in rural areas

2.2.5.2. Religious and cultural opposition in many regions across the globe

    2.2.6. Impact Analysis of Restraints on Future Forecast of the Market

CHAPTER 3. Market Entry Strategy

3.1. PESTLE Analysis

3.2. Value Chain Analysis

3.3. Competitive Analysis

3.3.1. Company Market Share Analysis

3.3.2. Porter’s Five Forces Analysis

CHAPTER 4. Global Intra-Uterine Contraceptive Device Market Size and Forecast (2013 – 2023)

4.1. Global Intra-Uterine Contraceptive Device Market, By Types

4.1.1. Hormonal Intra-Uterine Contraceptive Device

  4.1.1.1. Skyla

  4.1.1.2. Mirena

  4.1.1.3. Kyleena

4.1.2. Copper Intra-Uterine Contraceptive Device

    4.1.2.1. U-shaped

   4.1.2.2. Plain T-shaped

   4.1.2.3. Banded T-shaped

4.2. Global Intra-Uterine Contraceptive Device Market, By End-User

 4.2.1. Gynaecology Clinic

 4.2.2. Hospitals

4.3. Global Intra-Uterine Contraceptive Device Market, By Region

4.3.1. North America

4.3.2. Latin America

4.3.3. Europe

4.3.4. Asia-Pacific

4.3.5. Middle East and Africa

CHAPTER 5. Global Intra-Uterine Contraceptive Device Market, By Geography

5.1. North America Intra-Uterine Contraceptive Device Market

5.1.1. North America Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

5.1.2. North America Global Intra-Uterine Contraceptive Device Market, By End-User (USD Billion )

5.1.3. North America Global Intra-Uterine Contraceptive Device Market, By Country

  5.1.3.1. The U.S.

  5.1.3.2. Canada

  5.1.3.3. Mexico

  5.1.3.4. Rest of North America

5.1.3.4.1. Rest of North America Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

5.1.3.4.2. Rest of North America Intra-Uterine Contraceptive Device Market, By End-User (USD Billion )

5.2. Latin America Intra-Uterine Contraceptive Device Market

5.2.1. Latin America Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

5.2.2. Latin America Intra-Uterine Contraceptive Device Market By End-User (USD Billion )

5.2.3. Latin America Intra-Uterine Contraceptive Device Market By Country

   5.2.3.1. Argentina

   5.2.3.2. Brazil

   5.2.3.3. Colombia

   5.2.3.4. Rest of Latin America

  5.2.3.4.1. Rest of Latin America Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

  5.2.3.4.2. Rest of Latin America Intra-Uterine Contraceptive Device Market, By End-User (USD Billion )

5.3. Europe Intra-Uterine Contraceptive Device Market

5.3.1. Europe Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

5.3.2. Europe Intra-Uterine Contraceptive Device Market, By End-User (USD Billion )

5.3.3. Europe Intra-Uterine Contraceptive Device Market, By Country

   5.3.3.1. Germany

   5.3.3.2. France

   5.3.3.3. The U.K.

   5.3.3.4. Italy

   5.3.3.5. Spain

   5.3.3.6. France

   5.3.3.7. Monaco

   5.3.3.8. Estonia

5.3.4. Rest of Europe

   5.3.4.1. Rest of Europe Intra-Uterine Contraceptive Device Market By Types (USD Billion )

   5.3.4.2. Rest of Europe Intra-Uterine Contraceptive Device Market By End-User (USD Billion )

   5.4. Asia-Pacific Intra-Uterine Contraceptive Device Market

   5.4.1. Asia-Pacific Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

   5.4.2. Asia-Pacific Intra-Uterine Contraceptive Device Market, By End-User (USD Billion)

   5.4.3. Asia-Pacific Intra-Uterine Contraceptive Device Market, By Country

     5.4.3.1. China

     5.4.3.2. Japan

     5.4.3.3. Australia

     5.4.3.4. India

     5.4.3.5. South Korea

     5.4.3.6. New Zealand

     5.4.3.7. Rest of Asia-Pacific

    5.4.3.7.1. Rest of Asia-Pacific Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

    5.4.3.7.2. Rest of Asia-Pacific Intra-Uterine Contraceptive Device Market By End-User (USD Billion )

5.5. Middle East and Africa Intra-Uterine Contraceptive Device Market

5.5.1. Middle East and Africa Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

5.5.2. Middle East and Africa Intra-Uterine Contraceptive Device Market, By End-User (USD Billion)

5.5.3. Middle East and Africa Intra-Uterine Contraceptive Device Market, By Country

    5.5.3.1. Egypt

    5.5.3.2. Nigeria

    5.5.3.3. Ethiopia

    5.5.3.4. Iran

    5.5.3.5. Rest of Middle East and Africa

   5.5.3.5.1. Rest of Middle East and Africa Intra-Uterine Contraceptive Device Market, By Types (USD Billion )

   5.5.3.5.2. Rest of Middle East and Africa Intra-Uterine Contraceptive Device Market By End-User (USD Billion )

CHAPTER 6. Key Players and Strategic Developments

6.1. TEVA PHARMACEUTICAL INDUSTRIES LIMITED

6.1.1. Business Overview

6.1.2. Product and Service Offering

6.1.3. Financial Overview

6.1.4. Strategic Developments

6.2. EGEMEN INTERNATIONAL

6.2.1. Business Overview

6.2.2. Product and Service Offering

6.2.3. Financial Overview

6.2.4. Strategic Developments

6.3. Bayer HealthCare Pharmaceuticals Inc

6.3.1. Business Overview

6.3.2. Product and Service Offering

6.3.3. Financial Overview

6.3.4. Strategic Developments

6.4. Agile Therapeutics

6.4.1. Business Overview

6.4.2. Product and Service Offering

6.4.3. Financial Overview

6.4.4. Strategic Developments

6.5. Allergan plc

6.5.1. Business Overview

6.5.2. Product and Service Offering

6.5.3. Financial Overview

6.5.4. Strategic Developments

6.6. Pfizer

6.6.1. Business Overview

6.6.2. Product and Service Offering

6.6.3. Financial Overview

6.6.4. Strategic Developments

6.7. Lupin Pharmaceuticals Ltd

6.7.1. Business Overview

6.7.2. Product and Service Offering

6.7.3. Financial Overview

6.7.4. Strategic Developments

6.8. Pregna International Ltd.

6.8.1. Business Overview

6.8.2. Product and Service Offering

6.8.3. Financial Overview

6.8.4. Strategic Developments

6.9. SMB CORPORATION

6.9.1. Business Overview

6.9.2. Product and Service Offering

6.9.3. Financial Overview

6.9.4. Strategic Developments

6.10. Trimedic Supply Network Ltd.

6.10.1. Business Overview

6.10.2. Product and Service Offering

6.10.3. Financial Overview

6.10.4. Strategic Developments

6.11. Abbreviations

Global Intrauterine Contraceptive Device Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023